Deborah Diaz
Deborah Diaz's purchase track record
How the stock did after each of Deborah Diaz's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 3/6/2026 | FRST | $13K | +16.3% | +27.0% | +14.5% |
| 12/10/2025 | FRST | $20K | +2.1% | +22.3% | +5.5% |
| 12/12/2024 | FRST | $25K | -19.7% | -18.4% | -0.1% |
| 11/25/2024 | ACHR | $39K | +11.6% | +46.0% | -1.1% |
| 3/15/2024 | FRST | $20K | -17.6% | -0.6% | +10.0% |
| 6/13/2023 | ACHR | $54K | +48.2% | +44.3% | +6.3% |
| 2/24/2023 | FRST | $25K | -36.2% | -22.9% | +11.0% |
| 2/16/2023 | FRST | $20K | -34.0% | -21.8% | +6.8% |
| 6/17/2022 | FRST | $44K | -2.6% | -9.1% | +4.8% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
Raymond James Cuts Primis Financial Target to $18. Raymond James maintained its Strong Buy rating on Primis Financial Corp. but lowered its price target to $18. This adjustment aligns with the current analyst consensus, where the average target is $18.94. The stock is currently trading near its support level, reflecting a cautious market stance despite the firm's positive outlook.
Transaction History
| ACHR | ▲ Buy | Option Exercise | 19,102 | $0 | 6/26/2026 | View on chart |
| FRST | ▲ Buy | Open Market | 1,050 | $13K | 3/6/2026 | View on chart |
| FRST | ▲ Buy | Open Market | 1,608 | $20K | 12/10/2025 | View on chart |
| ACHR | ▲ Buy | Option Exercise | 54,644 | $0 | 6/21/2025 | View on chart |
| FRST | ▲ Buy | Open Market | 2,000 | $25K | 12/12/2024 | View on chart |
| ACHR | ▲ Buy | Open Market | 5,150 | $39K | 11/25/2024 | View on chart |
| ACHR | ▲ Buy | Option Exercise | 59,347 | $0 | 6/21/2024 | View on chart |
| FRST | ▲ Buy | Open Market | 1,650 | $20K | 3/15/2024 | View on chart |
| ACHR | ▲ Buy | Open Market | 12,000 | $54K | 6/13/2023 | View on chart |
| FRST | ▲ Buy | Open Market | 2,080 | $25K | 2/24/2023 | View on chart |
| FRST | ▲ Buy | Open Market | 1,650 | $20K | 2/16/2023 | View on chart |
| ACHR | ▼ Sell | Open Market | 11,000 | $33K | 9/22/2022 | View on chart |
| ACHR | ▲ Buy | Option Exercise | 33,389 | $0 | 9/16/2022 | View on chart |
| FRST | ▲ Buy | Open Market | 1,925 | $25K | 6/17/2022 | View on chart |
| FRST | ▲ Buy | Open Market | 1,500 | $19K | 6/17/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
Barclays Upgrades Archer to Overweight, Citing Military Focus
Barclays initiated coverage on Archer Aviation with an Overweight rating, highlighting the company's military-focused strategy as a key driver. This positive analyst action contrasts with a recent downgrade of competitor Joby Aviation, contributing to a 5% rise in Archer's stock price. The move underscores growing investor interest in Archer's eVTOL roadmap, particularly regarding potential defense sector applications.
Barclays Upgrades Archer to Overweight, Citing Military Focus. Barclays initiated coverage on Archer Aviation with an Overweight rating, highlighting the company's military-focused strategy as a key driver. This positive analyst action contrasts with a recent downgrade of competitor Joby Aviation, contributing to a 5% rise in Archer's stock price. The move underscores growing investor interest in Archer's eVTOL roadmap, particularly regarding potential defense sector applications.